Head-to-head · WeighScore
Effecty vs Options Medical Weight Loss
By GLP-1 ScorecardUpdated
Score comparison
Effecty has the higher recorded score — 83.7/100 to 65.5/100.
Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.
Before you choose
Before comparing the headline prices, the Effecty review and the Options Medical Weight Loss review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Effecty vs Pallas Health and Gala Health vs Options Medical Weight Loss compare each of them with another graded program, and the list of alternatives to Effecty ranks the programs closest to Effecty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Effecty | Options Medical Weight Loss |
|---|---|---|
| WeighScore | 83.7/100 | 65.5/100 |
| Grade | B | C |
| Site position | #21 | #238 |
| Semaglutide | $170/month before code; advertised $95 first month. Supply unconfirmed. | From $199/mo (compounded program, selected quote required) |
| Tirzepatide | $235/month before code; advertised $160 first month. Supply unconfirmed. | From $399/mo (compounded program, selected quote required) |
| Coverage | Nationwide shipping claimed; confirm treatment-specific eligibility. | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Medication-specific billing terms
- Dose-independent pricing advertised
- Separate Wegovy offer published
What to consider
- Selected total/supply unconfirmed
- Prescription sales described as final
- Assigned pharmacy and individual credentials unverified
Strengths
- Advertises a free consultation.
- Describes coaching and metabolic tracking as part of its GLP-1 program.
What to consider
- The advertised starting figures do not establish a selected program charge.
- Confirm any visit or testing fees and the cancellation terms.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.